Lower adalimumab trough levels are associated with higher bowel wall thickness in Crohn's disease

Bella Ungar*, Zohar Ben-Shatach, Limor Selinger, Alona Malik, Ahmad Albshesh, Shomron Ben-Horin, Rami Eliakim, Uri Kopylov, Dan Carter

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Lower adalimumab trough levels are associated with higher bowel wall thickness in Crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences